Clinical Impact of the Early Use of Sacubitril/Valsartan in Newly Diagnosed Heart Failure and Reduced Ejection Fraction.
In patients with newly-diagnosed HFrEF, the early initiation of sacubitril/valsartan was associated with a lower risk of the cumulative number of emergency visits and a greater improvement in LVEF.
Authors
- Chi‐Cheng Chuang (ORCID: https://orcid.org/0000-0003-1898-7264)
- Pao‐Hsien Chu (ORCID: https://orcid.org/0000-0003-0361-6348)
- Fu‐Chih Hsiao (ORCID: https://orcid.org/0000-0002-1032-4979)
- Tzyy-Jer Hsu
- Cze-Ci Chan
- Yu-Shien Ko
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-01
- DOI
- https://doi.org/10.6515/acs.202505_41(3).20250224c
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00